SOAT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.552400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.359800E-01
Normal-vs-Stage2
1.253430E-01
Normal-vs-Stage3
1.493770E-01
Normal-vs-Stage4
4.778800E-01
Stage1-vs-Stage2
9.357400E-01
Stage1-vs-Stage3
3.906400E-01
Stage1-vs-Stage4
8.815400E-01
Stage2-vs-Stage3
2.544800E-01
Stage2-vs-Stage4
9.134400E-01
Stage3-vs-Stage4
9.108400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.810200E-02
Normal-vs-AfricanAmerican
7.512400E-01
Normal-vs-Asian
2.268400E-01
Caucasian-vs-AfricanAmerican
4.208400E-01
Caucasian-vs-Asian
9.252600E-01
AfricanAmerican-vs-Asian
3.660000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.364400E-02
Normal-vs-Female
1.381220E-01
Male-vs-Female
4.016800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.876200E-01
Normal-vs-Age(41-60Yrs)
2.236200E-01
Normal-vs-Age(61-80Yrs)
6.949900E-02
Normal-vs-Age(81-100Yrs)
1.706430E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.113800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.993400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.344400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.365900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.721000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.536600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.989200E-01
Normal-vs-Daily Drinker
2.563400E-01
Normal-vs-Weekly Drinker
1.081420E-01
Normal-vs-Occasional Drinker
1.183980E-01
Normal-vs-Social Drinker
2.412800E-01
Non Drinker-vs-Daily Drinker
2.641800E-02
Non Drinker-vs-Weekly Drinker
9.621600E-01
Non Drinker-vs-Occasional Drinker
7.836800E-01
Non Drinker-vs-Social Drinker
3.709800E-01
Daily Drinker-vs-Weekly Drinker
7.116000E-02
Daily Drinker-vs-Occasional Drinker
2.794300E-02
Daily Drinker-vs-Social Drinker
1.006090E-02
Weekly Drinker-vs-Occasional Drinker
7.872800E-01
Weekly Drinker-vs-Social Drinker
4.366000E-01
Occasional Drinker-vs-Social Drinker
5.709200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.810600E-01
Normal-vs-Grade 2
2.779200E-01
Normal-vs-Grade 3
2.674400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.453800E-01
Grade 1-vs-Grade 3
6.281200E-01
Grade 1-vs-Grade 4
3.810600E-01
Grade 2-vs-Grade 3
2.360200E-01
Grade 2-vs-Grade 4
2.779200E-01
Grade 3-vs-Grade 4
2.674400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.620000E-02
Normal-vs-NonDiabetic
5.501700E-02
Diabetic-vs-NonDiabetic
8.220600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.663800E-01
Normal-vs-NoPancreatitis
7.429700E-02
Pancreatitis-vs-NoPancreatitis
7.937400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.831200E-01
Normal-vs-N1
1.576830E-01
N0-vs-N1
1.318970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.957670E-02
Normal-vs-TP53-NonMutant
1.184770E-01
TP53-Mutant-vs-TP53-NonMutant
1.881980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
